Natural compounds as safe therapeutic options for ulcerative colitis

被引:50
|
作者
Gupta, Mukta [1 ]
Mishra, Vijay [1 ]
Gulati, Monica [1 ]
Kapoor, Bhupinder [1 ]
Kaur, Amrinder [1 ]
Gupta, Reena [1 ]
Tambuwala, Murtaza M. [2 ]
机构
[1] Lovely Profess Univ, Sch Pharmaceut Sci, Phagwara 144411, Punjab, India
[2] Ulster Univ, Sch Pharm & Pharmaceut Sci, Coleraine BT52 1SA, Londonderry, North Ireland
关键词
Ulcerative colitis; Herbal constituents; Anti-ulcerogenic activity; Inflammatory bowel disease; ARCTIUM-LAPPA L; DEXTRAN SULFATE SODIUM; LONICERA-JAPONICA THUNB; TNBS-INDUCED COLITIS; RHEUM-TANGUTICUM POLYSACCHARIDE; TEA CAMELLIA-SINENSIS; ACID-INDUCED COLITIS; SYLVESTRE R. BR; GREEN TEA; GYMNEMA-SYLVESTRE;
D O I
10.1007/s10787-022-00931-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ulcerative colitis (UC) is a chronic inflammatory bowel disease of unknown etiology. Several conventional treatments for UC such as corticosteroids, immunosuppressive agents, tumor necrosis factor antagonist, integrin blockers, and interleukin antagonist, and salicylates are available but are associated with the various limitations and side-effects. None of the above treatments helps to achieve the ultimate goal of the therapy, i.e., maintenance of remission in the long-term. Natural remedies for the treatment of UC show comparatively less side effects as compared to conventional approaches, and affordable. The current review presents details on the role of herbal drugs in the treatment and cure of UC. Google, PubMed, Web of Science, and Scopus portals have been searched for potentially relevant literature to get the latest developments and updated information related to use of natural drugs in the treatment of UC. Natural products have been used over centuries to treat UC. Some of the essential herbal constituents exhibiting antiulcerogenic activity include gymnemic acid (Gymnema sylvestre), shagoal (Zingiber officinale), catechin (Camellia sinensis), curcumin (Curcuma longa), arctigenin (Arctium lappa), and boswellic acid (Boswellia serrata). Although many plant-derived products have been recommended for UC, further research to understand the exact molecular mechanism is still warranted to establish their usefulness clinically.
引用
收藏
页码:397 / 434
页数:38
相关论文
共 50 条
  • [31] THERAPEUTIC CONSIDERATIONS IN CHRONIC ULCERATIVE COLITIS
    PALMER, WL
    KIRSNER, JB
    MARSHALL, H
    ANNALS OF INTERNAL MEDICINE, 1950, 32 (04) : 627 - 639
  • [32] Lecithin as a Therapeutic Agent in Ulcerative Colitis
    Stremmel, Wolfgang
    Gauss, Annika
    DIGESTIVE DISEASES, 2013, 31 (3-4) : 388 - 390
  • [33] An apPEAling new therapeutic for ulcerative colitis?
    McKernan, Declan P.
    Finn, David P.
    GUT, 2014, 63 (08) : 1207 - U36
  • [34] A review of the therapeutic management of ulcerative colitis
    Aslam, Nasar
    Lo, Sheng Wei
    Sikafi, Rafid
    Barnes, Tom
    Segal, Jonathan
    Smith, Philip J.
    Limdi, Jimmy K.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [35] Therapeutic Strategies for the Management of Ulcerative Colitis
    Ng, Siew C.
    Kamm, Michael A.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (06) : 935 - 950
  • [36] Disease clearance in ulcerative colitis: Setting the therapeutic goals for future in the treatment of ulcerative colitis
    Ramos, Laura
    Teo-Loy, Jeny
    Barreiro-de Acosta, Manuel
    FRONTIERS IN MEDICINE, 2023, 9
  • [37] EXPLORING THE PATHOGENESIS FROM FERROPTOSIS AND SCREENING NATURAL DRUGS FOR THERAPEUTIC POTENTIALS OF ULCERATIVE COLITIS
    Gong, Zhuozhi
    Liu, Tao
    Song, Gengqing
    Wang, Qianying
    Yan, He
    Cao, Zeng
    Yao, Mengxi
    Sun, Zikuan
    Wei, Wei
    GASTROENTEROLOGY, 2023, 164 (06) : S946 - S946
  • [38] Novel Therapeutic Options for People with Ulcerative Colitis: An Update on Recent Developments with Janus Kinase (JAK) Inhibitors
    Troncone, Edoardo
    Marafini, Irene
    Blanco, Giovanna Del Vecchio
    Di Grazia, Antonio
    Monteleone, Giovanni
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2020, 13 : 131 - 139
  • [39] New treatment options for moderate to severe ulcerative colitis
    Kucharzik, T.
    Nitschmann, S.
    INTERNIST, 2020, 61 (04): : 433 - 436
  • [40] ULCERATIVE-COLITIS AND POLYPOSIS COLI - SURGICAL OPTIONS
    SACKIER, JM
    WOOD, CB
    SURGICAL CLINICS OF NORTH AMERICA, 1988, 68 (06) : 1319 - 1338